FdaApplication
NDA 020130
Identifiers
- fda_app_no: NDA020130
Properties
| Property | Value |
|---|---|
| applicant_name | ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD |
| application_type | NDA |
| approval_date | 1996-10-09 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ESTROSTEP 21 | ETHINYL ESTRADIOL; NORETHINDRONE ACETATE | 0.02MG,0.03MG,0.035MG;1MG,1MG,1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL-21 |
| ESTROSTEP FE | ETHINYL ESTRADIOL; NORETHINDRONE ACETATE | 0.02MG,0.03MG,0.035MG;1MG,1MG,1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL-28 |
2 products